MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

Search

Lisata Therapeutics

Cerrado

2.01 -2.9

Resumen

Variación precio

24h

Actual

Mínimo

1.88

Máximo

2.1

Métricas clave

By Trading Economics

Empleados

26

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

-5.9M

14M

Apertura anterior

4.91

Cierre anterior

2.01

Lisata Therapeutics Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

8 ene 2026, 23:08 UTC

Adquisiciones, fusiones, absorciones

Rio Tinto, Glencore in Talks to Form World's Biggest Miner -- 3rd Update

8 ene 2026, 21:39 UTC

Adquisiciones, fusiones, absorciones

Glencore, Rio Tinto Restart Merger Talks -- 2nd Update

8 ene 2026, 20:54 UTC

Adquisiciones, fusiones, absorciones

Glencore, Rio Tinto Restart Merger Talks -- Update

8 ene 2026, 20:44 UTC

Adquisiciones, fusiones, absorciones

Glencore, Rio Tinto Restart Merger Talks

8 ene 2026, 17:05 UTC

Adquisiciones, fusiones, absorciones

Chinese Anta Sports Products Offers to Buy Pinault Family's Stake in Puma, Reuters Says, Citing Unnamed Sources

8 ene 2026, 16:43 UTC

Principales Movimientos del Mercado

Babcock & Wilcox Shares Rise on Siemens Deal for Data Center Project

8 ene 2026, 23:44 UTC

Charlas de Mercado

Nikkei May Rise on Weaker Yen -- Market Talk

8 ene 2026, 23:37 UTC

Charlas de Mercado

Gold Steady, Underpinned by Geopolitical Risks -- Market Talk

8 ene 2026, 22:42 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

8 ene 2026, 22:42 UTC

Charlas de Mercado

RBA Still Battling a Troubling Inflation Outlook, Says TD -- Market Talk

8 ene 2026, 22:30 UTC

Adquisiciones, fusiones, absorciones

Glencore, Rio Tinto Confirm Early Merger Talks -- Barrons.com

8 ene 2026, 21:53 UTC

Ganancias

These Stocks Moved the Most Today: Lockheed, Northrop, Alphabet, Applied Digital, Bloom Energy, Neogen, and More -- Barrons.com

8 ene 2026, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

8 ene 2026, 21:50 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

8 ene 2026, 21:10 UTC

Adquisiciones, fusiones, absorciones

Rio Tinto Says Current Expectation That Any Deal Would Involve Buying Glencore Via Scheme of Arrangement

8 ene 2026, 21:09 UTC

Charlas de Mercado

Oil Rises As Trump Said to Back Russia Sanctions Bill -- Market Talk

8 ene 2026, 21:09 UTC

Adquisiciones, fusiones, absorciones

Rio Tinto Confirms in Talks With Glencore Over Possible Merger

8 ene 2026, 20:21 UTC

Charlas de Mercado

U.S. Natural Gas Futures Down Despite Inventory Draw -- Market Talk

8 ene 2026, 19:44 UTC

Charlas de Mercado

Gold's Shine Masks Deep Drops in Canada Steel, Aluminum Exports -- Market Talk

8 ene 2026, 18:50 UTC

Charlas de Mercado

Mexico's Industrial Production Seen Lower in November -- Market Talk

8 ene 2026, 17:48 UTC

Ganancias

These Stocks Are Moving the Most Today: Lockheed, Northrop, Alphabet, Applied Digital, Bloom Energy, Neogen, and More -- Barrons.com

8 ene 2026, 17:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

8 ene 2026, 17:20 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

8 ene 2026, 17:20 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

8 ene 2026, 17:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

8 ene 2026, 16:45 UTC

Charlas de Mercado

Goldman Lifts 1H LME Copper Forecast -- Market Talk

8 ene 2026, 16:03 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

8 ene 2026, 16:03 UTC

Charlas de Mercado

Currency Markets Could Be Underpricing Medium-Term Risks -- Market Talk

8 ene 2026, 16:02 UTC

Charlas de Mercado

U.S. Natural Gas Inventories Fall As Expected -- Market Talk

8 ene 2026, 15:23 UTC

Adquisiciones, fusiones, absorciones

Paramount Defends Its Hostile Bid for Warner -- Update

Comparación entre iguales

Cambio de precio

Lisata Therapeutics Esperado

Consenso

By TipRanks

0 ratings

0

Comprar

0

Mantener

0

Vender

Finanzas

$

Acerca de Lisata Therapeutics

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
help-icon Live chat